Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04610788Completed
Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH
Pulmonary Artery HypertensionScleroderma
PrincipalinvestigatorStart date: 2019-04-15
NCT01042158Phase 4Completed
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Connective Tissue DiseasePulmonary Arterial HypertensionPulmonary Hypertension+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Hypertension, PulmonaryScleroderma
Similarity Score9%

Seetha Shankaran, MD

Wayne State University

Related
49 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score4%

Dale L. Phelps, MD

University of Rochester

Related
10 trials

Shared therapeutic areas:

Hypertension, Pulmonary
Similarity Score4%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score4%

Abhik Das, PhD

RTI International

Related
31 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score4%

Michele C. Walsh, MD MS

Case Western Reserve University, Rainbow Babies and Children's Hospital

Related
11 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score4%

Neil N. Finer, MD

University of California, San Diego

Related
11 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score4%

Edward F. Donovan, MD

Children's Hospital Medical Center, Cincinnati

Related
21 trials

Shared therapeutic areas:

Hypertension, Pulmonary
Similarity Score4%

Barbara J. Stoll, MD

Emory University

Related
33 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score4%

Krisa P Van Meurs, MD

Stanford University

Related
11 trials

Shared therapeutic areas:

Hypertension, Pulmonary

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04610788PrincipalInvestigator

Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH

Pulmonary Artery HypertensionScleroderma
Completed
NCT01042158Phase 4PrincipalInvestigator

A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis

Connective Tissue DiseasePulmonary Arterial HypertensionPulmonary Hypertension+2 more
Completed

All 2 trials loaded